Last updated
라이플렉스사이언스 (Lifleks Science): Capital Raising
Korean anti-aging RNA therapeutics company Lifleks Science closed a 7 billion won (about US$5M) Series A led by a syndicate including KDB, Medytox Ventures, Murex Partners, and Korea Science & Technology Holdings, among others. Proceeds fund preclinical-to-clinical progression of its osteoarthritis RNA therapeutic (clinical entry targeted for 2H 2027) and three follow-on pipeline programmes in obesity, kidney and heart disease.
Source: WOWTALE — Korea startup rounds
- Who
- 라이플렉스사이언스 (Lifleks Science) · South Korea
- What happened
- Korean anti-aging RNA therapeutics company Lifleks Science closed a 7 billion won (about US$5M) Series A led by a syndicate including KDB, Medytox Ventures, Murex Partners, and Korea Science & Technology Holdings, among others. Proceeds fund preclinical-to-clinical progression of its osteoarthritis RNA therapeutic (clinical entry targeted for 2H 2027) and three follow-on pipeline programmes in obesity, kidney and heart disease.
- When
- 2026-11-12
- So what
- Fresh capital is a hiring signal before it is anything else.
The leadership read
Fresh capital is a hiring signal before it is anything else. For 라이플렉스사이언스 (Lifleks Science), a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where 라이플렉스사이언스 (Lifleks Science) hires first across Asia; that is where the capital is really pointed.
Market context: Backdrop: a 97.6 (Neutral) Talent Market Index (down 3.4 on the month) with Asia activity rising (+4.2pts).
라이플렉스사이언스 (Lifleks Science): 1 signal in the last 90 days.
MitchelLake in this thematic
More signals across Asia
Capital Raising · Asia
EuroSports →Luxury car dealer EuroSports reported losses and is seeking funding to support its business, with its auditors/board raising material uncertainty over its ability to continue operating.
Capital Raising · Asia
Avatar Capital Partners →Avatar Capital Partners closed the first close of Fund II at US$156 million and is targeting US$300 million for a fund focused on Japan's living sector. It also formed a strategic partnership with GCM Grosvenor and the Teacher Retirement System of Texas.
Capital Raising · Asia
Hangzhou Eli Radiopharma Co., Ltd. →Eli Radiopharma completed a Series A financing of nearly RMB 400 million to advance its radiopharmaceutical pipeline toward clinical development.
Capital Raising · Asia
Hosin →Chinese chip firm Hosin is debuting on the Hong Kong market, indicating a public listing (IPO) and fresh equity capital raise.
Capital Raising · Asia
lingyuan intelligence →Shenzhen-based underwater AI startup Lingyuan Intelligence raised a $1.5M seed round to build underwater AI technology.
Capital Raising · Asia
NearMe →Japanese company NearMe raised $3.26M to grow its AI shared-ride transport business.
Where this lands in our work
- Executive Search →
Capital raised becomes leadership hired — the executive build follows the announcement.
- Scale-up →
Each doubling of the team forces a new leadership layer — the graduation pattern.
- Executive Search: Asia →
Our Asia practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record